Product Information
CLINDAMYCIN PHOSP 1% LOTION is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2447 per ML under NDC 45802012801. Its NADAC has been published 283 times since May 5, 2021.
FDA first approved this application on Mar 8, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802012801
Classification
Generic
Dosage Form
LOTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA214604FDA Approved
3/8/2021
TE Code
AB
On Market Since
3/31/2021
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOSP 1% LOTION has been published 283 times since May 5, 2021, and over the history we have for it it has declined 78.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2447 per ML |
|---|---|
| All-time high | $1.1382 (Jul 14, 2021) |
| All-time low | $0.2447 (Sep 23, 2026) |
| 52-week high | $0.3195 |
| 52-week low | $0.2447 |
| Median price | $0.3650 |
| Average price | $0.4929 |
| Largest weekly change | +38.7% (Jun 19, 2024) |
| Weeks tracked | 283 |
| Tracking since | May 5, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOSP 1% LOTION?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSP 1% LOTION, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2447 per ML (NDC 45802012801), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PHOSP 1% LOTION changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOSP 1% LOTION has declined 78.4%. It has been tracked across 283 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSP 1% LOTION?
Since May 5, 2021, the NADAC for CLINDAMYCIN PHOSP 1% LOTION has ranged from a low of $0.2447 (Sep 23, 2026) to a high of $1.1382 (Jul 14, 2021), with a median of $0.3650 per ML.
Are there cheaper alternatives to CLINDAMYCIN PHOSP 1% LOTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN PHOSP 1% LOTION in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN PHOSP 1% LOTION?
CLINDAMYCIN PHOSP 1% LOTION (NDC 45802012801) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.